Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apoptosis | 31 | 2023 | 9714 | 2.540 |
Why?
|
Apoptosis Regulatory Proteins | 10 | 2023 | 1157 | 1.670 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 14 | 2023 | 1431 | 1.590 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 3 | 2019 | 92 | 1.150 |
Why?
|
Mitochondria | 12 | 2024 | 3522 | 0.980 |
Why?
|
bcl-2-Associated X Protein | 6 | 2023 | 293 | 0.880 |
Why?
|
Cell Death | 5 | 2023 | 1693 | 0.740 |
Why?
|
bcl-X Protein | 9 | 2023 | 413 | 0.730 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 3 | 2023 | 75 | 0.660 |
Why?
|
Neoplasms | 12 | 2023 | 21507 | 0.650 |
Why?
|
Antineoplastic Agents | 8 | 2022 | 13635 | 0.610 |
Why?
|
Drug Resistance, Neoplasm | 9 | 2023 | 5148 | 0.560 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 427 | 0.510 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2016 | 984 | 0.470 |
Why?
|
Interleukins | 3 | 2016 | 788 | 0.450 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2017 | 683 | 0.440 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 5 | 2009 | 1373 | 0.440 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1702 | 0.400 |
Why?
|
Lymphoma, Primary Effusion | 1 | 2010 | 17 | 0.380 |
Why?
|
Drug Therapy | 1 | 2013 | 497 | 0.370 |
Why?
|
Interleukin-4 | 3 | 2009 | 1139 | 0.350 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2019 | 3562 | 0.330 |
Why?
|
Germinal Center | 3 | 2010 | 373 | 0.320 |
Why?
|
Genes, myc | 1 | 2009 | 399 | 0.320 |
Why?
|
Proto-Oncogene Proteins | 4 | 2023 | 4555 | 0.310 |
Why?
|
Sulfonamides | 4 | 2022 | 1934 | 0.280 |
Why?
|
Nitrophenols | 2 | 2017 | 172 | 0.270 |
Why?
|
ras Proteins | 3 | 2017 | 1062 | 0.270 |
Why?
|
Cell Line, Tumor | 18 | 2022 | 16646 | 0.270 |
Why?
|
Vero Cells | 2 | 2021 | 484 | 0.270 |
Why?
|
Boronic Acids | 1 | 2010 | 966 | 0.270 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.270 |
Why?
|
Multiple Myeloma | 3 | 2022 | 5147 | 0.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 8400 | 0.270 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9387 | 0.260 |
Why?
|
Ovarian Neoplasms | 6 | 2020 | 4815 | 0.260 |
Why?
|
HeLa Cells | 4 | 2019 | 3119 | 0.250 |
Why?
|
Pyrazines | 1 | 2010 | 1232 | 0.240 |
Why?
|
Lymphoma, B-Cell | 3 | 2019 | 929 | 0.240 |
Why?
|
MAP Kinase Signaling System | 3 | 2017 | 1522 | 0.240 |
Why?
|
Animals | 25 | 2024 | 168368 | 0.230 |
Why?
|
Caspases | 2 | 2023 | 927 | 0.220 |
Why?
|
Mitochondrial Membranes | 1 | 2024 | 174 | 0.220 |
Why?
|
Mice | 16 | 2024 | 81002 | 0.210 |
Why?
|
Biphenyl Compounds | 2 | 2017 | 909 | 0.210 |
Why?
|
Immunoglobulin Light Chains | 1 | 2022 | 274 | 0.200 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10142 | 0.190 |
Why?
|
Humans | 48 | 2023 | 739398 | 0.190 |
Why?
|
Signal Transduction | 12 | 2023 | 23355 | 0.180 |
Why?
|
Silanes | 1 | 2019 | 28 | 0.180 |
Why?
|
Nanoparticles | 2 | 2023 | 1906 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2948 | 0.180 |
Why?
|
Radioactivity | 1 | 2020 | 63 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 358 | 0.170 |
Why?
|
Alkylating Agents | 1 | 2019 | 138 | 0.170 |
Why?
|
Silicon Dioxide | 1 | 2019 | 212 | 0.160 |
Why?
|
BRCA1 Protein | 2 | 2016 | 1143 | 0.160 |
Why?
|
Cell Survival | 5 | 2020 | 5877 | 0.160 |
Why?
|
Transaminases | 1 | 2018 | 201 | 0.150 |
Why?
|
Amyloid | 1 | 2022 | 794 | 0.150 |
Why?
|
STAT6 Transcription Factor | 2 | 2008 | 199 | 0.150 |
Why?
|
Virus Internalization | 1 | 2021 | 499 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 5 | 2018 | 5502 | 0.150 |
Why?
|
Cells, Cultured | 3 | 2022 | 19220 | 0.150 |
Why?
|
Doxorubicin | 2 | 2016 | 2218 | 0.150 |
Why?
|
Membrane Proteins | 1 | 2013 | 7862 | 0.140 |
Why?
|
Pyrazoles | 2 | 2017 | 1963 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2022 | 1504 | 0.140 |
Why?
|
Pathology | 1 | 2019 | 272 | 0.130 |
Why?
|
Heat-Shock Proteins | 1 | 2020 | 825 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 648 | 0.130 |
Why?
|
Macrophages | 3 | 2019 | 5631 | 0.130 |
Why?
|
Dexamethasone | 1 | 2022 | 1948 | 0.130 |
Why?
|
Niacinamide | 1 | 2017 | 415 | 0.130 |
Why?
|
Longevity | 1 | 2022 | 1066 | 0.130 |
Why?
|
bcl-Associated Death Protein | 1 | 2014 | 107 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2023 | 5154 | 0.120 |
Why?
|
Topoisomerase Inhibitors | 1 | 2013 | 18 | 0.120 |
Why?
|
Age Factors | 3 | 2021 | 18349 | 0.120 |
Why?
|
Mice, SCID | 3 | 2019 | 2716 | 0.120 |
Why?
|
Disease | 1 | 2019 | 683 | 0.110 |
Why?
|
Fibroblasts | 1 | 2024 | 4137 | 0.110 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2238 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 670 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1310 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2018 | 1168 | 0.110 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2015 | 232 | 0.110 |
Why?
|
Cisplatin | 2 | 2019 | 1617 | 0.100 |
Why?
|
MicroRNAs | 2 | 2023 | 3712 | 0.100 |
Why?
|
Epigenomics | 1 | 2017 | 877 | 0.100 |
Why?
|
Lung Neoplasms | 4 | 2023 | 12985 | 0.100 |
Why?
|
Organ Specificity | 1 | 2016 | 2004 | 0.100 |
Why?
|
Proteomics | 2 | 2022 | 3584 | 0.100 |
Why?
|
Environmental Exposure | 2 | 2023 | 4220 | 0.100 |
Why?
|
Janus Kinase 2 | 1 | 2014 | 527 | 0.100 |
Why?
|
DNA Repair | 2 | 2018 | 2030 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1674 | 0.100 |
Why?
|
DNA Damage | 2 | 2018 | 2419 | 0.100 |
Why?
|
Homeostasis | 2 | 2019 | 3348 | 0.100 |
Why?
|
E2F3 Transcription Factor | 1 | 2010 | 40 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11410 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2017 | 9122 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3435 | 0.090 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1380 | 0.090 |
Why?
|
Immunologic Factors | 2 | 2016 | 1571 | 0.090 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2010 | 241 | 0.090 |
Why?
|
Immunotherapy | 2 | 2023 | 4391 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 21863 | 0.080 |
Why?
|
Neoplasm Proteins | 3 | 2010 | 3694 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2016 | 1374 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2014 | 601 | 0.080 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2008 | 91 | 0.080 |
Why?
|
Herpesvirus 8, Human | 1 | 2010 | 258 | 0.080 |
Why?
|
Unfolded Protein Response | 1 | 2010 | 230 | 0.080 |
Why?
|
Virion | 1 | 2010 | 435 | 0.080 |
Why?
|
Diphenylamine | 2 | 2018 | 50 | 0.080 |
Why?
|
Doxycycline | 1 | 2009 | 327 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2022 | 3101 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 2008 | 246 | 0.080 |
Why?
|
Transcriptional Activation | 1 | 2013 | 1783 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2455 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2268 | 0.070 |
Why?
|
Receptors, Interleukin-21 | 2 | 2016 | 33 | 0.070 |
Why?
|
Child | 3 | 2023 | 77033 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 694 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2014 | 2933 | 0.070 |
Why?
|
Air Pollutants | 1 | 2020 | 2801 | 0.070 |
Why?
|
Mice, Nude | 3 | 2018 | 3692 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 4189 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 761 | 0.070 |
Why?
|
Mutation | 5 | 2018 | 29658 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2018 | 3364 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 689 | 0.070 |
Why?
|
Fatal Outcome | 1 | 2010 | 1850 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2016 | 409 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1592 | 0.060 |
Why?
|
Medical Oncology | 1 | 2016 | 2217 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2007 | 470 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 2918 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3614 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2267 | 0.060 |
Why?
|
Glioma | 1 | 2018 | 3378 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15511 | 0.060 |
Why?
|
DNA Replication | 1 | 2010 | 1389 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1800 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 109 | 0.060 |
Why?
|
Down-Regulation | 1 | 2010 | 2999 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9782 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 181 | 0.050 |
Why?
|
Benzamides | 2 | 2018 | 1374 | 0.050 |
Why?
|
Cell Cycle | 1 | 2010 | 2960 | 0.050 |
Why?
|
Female | 13 | 2021 | 378853 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 244 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2502 | 0.050 |
Why?
|
Lymphoma | 1 | 2010 | 1873 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6310 | 0.050 |
Why?
|
Spheroids, Cellular | 1 | 2023 | 342 | 0.050 |
Why?
|
Child, Preschool | 1 | 2023 | 40802 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2022 | 3498 | 0.050 |
Why?
|
Up-Regulation | 1 | 2009 | 4205 | 0.050 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2023 | 555 | 0.050 |
Why?
|
Phase Transition | 1 | 2020 | 75 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6610 | 0.040 |
Why?
|
Infant | 1 | 2021 | 34923 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2020 | 11460 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 2020 | 165 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2013 | 10961 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5522 | 0.040 |
Why?
|
Cell Movement | 1 | 2010 | 5221 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9259 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2007 | 2965 | 0.040 |
Why?
|
Cities | 1 | 2020 | 512 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2016 | 62693 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2024 | 989 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1112 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 294 | 0.040 |
Why?
|
Pregnancy Proteins | 1 | 2018 | 229 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2017 | 123 | 0.040 |
Why?
|
Survival Analysis | 1 | 2010 | 10247 | 0.040 |
Why?
|
Indolizines | 1 | 2016 | 37 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2020 | 7709 | 0.040 |
Why?
|
Cyclic N-Oxides | 1 | 2016 | 78 | 0.040 |
Why?
|
Organoids | 1 | 2023 | 687 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10945 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9609 | 0.040 |
Why?
|
Glutarates | 1 | 2018 | 235 | 0.040 |
Why?
|
Pyridinium Compounds | 1 | 2016 | 84 | 0.040 |
Why?
|
Surface Properties | 1 | 2019 | 1181 | 0.040 |
Why?
|
Cell-Free System | 1 | 2016 | 346 | 0.040 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 44 | 0.030 |
Why?
|
Piperazines | 2 | 2017 | 2480 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 170 | 0.030 |
Why?
|
Phosphorylation | 3 | 2014 | 8416 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 576 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2023 | 1920 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1867 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2417 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3193 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2016 | 180 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15070 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 2016 | 589 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1777 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 20676 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2018 | 990 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 803 | 0.030 |
Why?
|
Male | 5 | 2021 | 349022 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2013 | 188 | 0.030 |
Why?
|
Benzoquinones | 1 | 2013 | 201 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 869 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2184 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1904 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2014 | 2552 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2016 | 1369 | 0.030 |
Why?
|
Immunomodulation | 1 | 2016 | 540 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2307 | 0.030 |
Why?
|
Platinum | 1 | 2013 | 229 | 0.030 |
Why?
|
Paclitaxel | 1 | 2019 | 1701 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1662 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2084 | 0.030 |
Why?
|
Adult | 3 | 2022 | 213394 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1285 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2013 | 320 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2016 | 5076 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2013 | 440 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2016 | 915 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 212863 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 875 | 0.020 |
Why?
|
Adenine | 1 | 2016 | 940 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2845 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 801 | 0.020 |
Why?
|
Aged | 2 | 2021 | 162698 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 435 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4395 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5742 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 302 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2200 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5293 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1793 | 0.020 |
Why?
|
Cell Membrane | 1 | 2019 | 3747 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2016 | 57650 | 0.020 |
Why?
|
Permeability | 1 | 2011 | 739 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2141 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14558 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2933 | 0.020 |
Why?
|
TYK2 Kinase | 1 | 2008 | 38 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2013 | 788 | 0.020 |
Why?
|
Indoles | 1 | 2017 | 1832 | 0.020 |
Why?
|
Metalloproteins | 1 | 2008 | 102 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2851 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2511 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2019 | 3087 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2530 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1597 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2008 | 262 | 0.020 |
Why?
|
Staurosporine | 1 | 2008 | 251 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40050 | 0.020 |
Why?
|
Interferon Regulatory Factors | 1 | 2008 | 268 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15987 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2007 | 51 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2010 | 578 | 0.020 |
Why?
|
Protein Binding | 2 | 2010 | 9375 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2133 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3848 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2507 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2378 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2010 | 1150 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13816 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2007 | 698 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5652 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 1513 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4374 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2008 | 1348 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6113 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6871 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7897 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2901 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5401 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16301 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5830 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2910 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2008 | 3007 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3802 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 35326 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3485 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10455 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 13002 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9622 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 10534 | 0.010 |
Why?
|